Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02865330

Spanish Urological Association Registry of Patients on Active Surveillance

Status
Recruiting
Phase
Study type
Observational
Enrollment
946 (estimated)
Sponsor
Fundación Instituto Valenciano de Oncología · Academic / Other
Sex
Male
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Description: Multicentre observational study, not randomized. Ambispective character (retro and prospective). Opened to any member of the Asociación Española de Urología (AEU), public and private medicine. Justification: Active surveillance is a strategy proposed to control the overtreatment derived from the opportunist screening in prostate cancer (PCa). Its development in our country is erratic and different in every Center. This database tries to include most of patients included in active surveillance in Spain with a few minimal inclusion criteria. Multicentre registry and follow up of the active surveillance in Spain. Hypothesis: Mortality cancer specific for PCa includible in active surveillance to 15 years is lower than 5 %.

Conditions

Interventions

TypeNameDescription
OTHERRegistryNational Registry of patients with prostate cancer as monitored through active surveillance, with the intention of testing the hypothesis that cancer-specific mortality in very low-risk and low-risk patients is less than 5% at 15 years.

Timeline

Start date
2014-07-01
Primary completion
2019-06-01
Completion
2034-07-01
First posted
2016-08-12
Last updated
2018-02-12

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02865330. Inclusion in this directory is not an endorsement.